Latest Articles
Lucy Mecklenburgh Shares Health Update; After Surgery for 'Her Debilitating Endometriosis Battle' - International Business Times UK
Lucy Mecklenburgh Shares Health Update; After Surgery for 'Her Debilitating Endometriosis Battle' International Business Times UK
Published: Dec. 4, 2025, 7:09 p.m.
Amazon Cyber Monday deals still live 2025: Shop AirPods, Fire TV Sticks, Bose speakers - Mashable
Amazon Cyber Monday deals still live 2025: Shop AirPods, Fire TV Sticks, Bose speakers Mashable
Published: Dec. 4, 2025, 6:42 p.m.
Radio-Canada greenlights doc from Duo, Poutine Studios - playbackonline.ca
Radio-Canada greenlights doc from Duo, Poutine Studios playbackonline.ca
Published: Dec. 4, 2025, 4:53 p.m.
Ancient genetics and modern pollutants could provide a clue to endometriosis risk - Medical Xpress
Ancient genetics and modern pollutants could provide a clue to endometriosis risk Medical Xpress
Published: Dec. 4, 2025, 4:40 p.m.
Ancient Genes, Modern Pollutants: Clue to Endometriosis Risk - Mirage News
Ancient Genes, Modern Pollutants: Clue to Endometriosis Risk Mirage News
Published: Dec. 4, 2025, 3:54 p.m.
Former ‘First Take’ host Molly Qerim posts rare heartfelt request to help the friend she owes everything - The Times of India
Former ‘First Take’ host Molly Qerim posts rare heartfelt request to help the friend she owes everything The Times of India
Published: Dec. 4, 2025, 3:13 p.m.
Ancient genetics and modern pollutants could provide a clue to endometriosis risk - Bournemouth University
Ancient genetics and modern pollutants could provide a clue to endometriosis risk Bournemouth University
Published: Dec. 4, 2025, 1:48 p.m.
Absci Announces First Participants Dosed In Phase 1/2A Headline Trial - TradingView
Absci Announces First Participants Dosed In Phase 1/2A Headline Trial TradingView
Published: Dec. 4, 2025, 1:24 p.m.
Absci Announces First Participants Dosed in Phase 1/2a HEADLINE™ Trial of AI-Designed Antibody ABS-201™ for Androgenetic Alopecia - The Manila Times
Absci Announces First Participants Dosed in Phase 1/2a HEADLINE™ Trial of AI-Designed Antibody ABS-201™ for Androgenetic Alopecia The Manila Times
Published: Dec. 4, 2025, 1:22 p.m.
Absci Announces First Participants Dosed in Phase 1/2a - GlobeNewswire
Absci Announces First Participants Dosed in Phase 1/2a GlobeNewswire
Published: Dec. 4, 2025, 1 p.m.
Link copied to clipboard!